Markets

Larimar Therapeutics Appoints John Harlow As President and COO, Effective September 29

Sep 29, 2026 · 04:06 PM ET· updated 1h ago

Larimar Therapeutics, Inc. (Larimar) (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the appointment of John Harlow as President and

Why It Matters

Larimar hired a new leader to help run the company. When a biotech company gets an experienced president, watch if they speed up their drug development work.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

LRMR3.13

-0.04 (-1.32%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.